Effects of antibiotics on human microbiota and subsequent disease

Annual Review of Microbiology

Volumn 68, Issue , 2014, Pages 217-235

  Keeney, Kristie M ^a   Yurist Doutsch, Sophie ^a   Arrieta, Marie Claire ^a   Finlay, B Brett ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antibiotics; Enteric; Microbiota; Pathogen

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ASTHMA; ATOPY; BACTERIAL COLONIZATION; CITROBACTER; CITROBACTER RODENTIUM; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; GASTROINTESTINAL TRACT; HUMAN; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; MICROBIAL COMMUNITY; MICROFLORA; NONHUMAN; OBESITY; REVIEW; RHEUMATOID ARTHRITIS; SALMONELLA; SALMONELLA TYPHIMURIUM; TRANSCRIPTOMICS; ANIMAL; BACTERIAL INFECTION; DISEASE; DRUG EFFECTS; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DISEASE; HUMANS; MICROBIOTA;

EID: 84907528345     PISSN: 00664227     EISSN: 15453251     Source Type: Book Series    
DOI: 10.1146/annurev-micro-091313-103456     Document Type: Review

References (135)

1. Adler JL, Anderson RL, Boring JR, Nahmias AJ. 1970. A protracted hospital-associated outbreak of salmonellosis due to a multiple-antibiotic-resistant strain of Salmonella indiana. J. Pediatr. 77(6):970-75
2. Angelakis E, Armougom F, Million M, Raoult D. 2012. The relationship between gut microbiota and weight gain in humans. Future Microbiol. 7(1):91-109
3. Antunes LCM, Finlay BB. 2011. A comparative analysis of the effect of antibiotic treatment and enteric infection on intestinal homeostasis. Gut Microbes 2(2):105-8
4. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. 2009. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS ONE 4(9):e7125
5. Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, et al. 2011. Helicobacter pylori infection prevents allergic asthma in mousemodels through the induction of regulatoryTcells. J. Clin. Investig. 121(8):3088-93
6. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, et al. 2011. Enterotypes of the human gut microbiome. Nature 473(7346):174-80
7. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331(6015):337-41
8. Balamurugan R,GeorgeG,Kabeerdoss J,Hepsiba J, Chandragunasekaran AMS, Ramakrishna BS. 2010. Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. Br. J. Nutr. 103(3):335-38
9. Beaugerie L, Flahault A, Barbut F, Atlan P, Lalande V, et al. 2003. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment. Pharmacol. Ther. 17(7):905-12
10. Bergstrom KSB, Kissoon-Singh V, Gibson DL, Ma C, Montero M, et al. 2010. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 6(5):e1000902
11. Bik EM, Long CD, Armitage GC, Loomer P, Emerson J, et al. 2010. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J. 4(8):962-74
12. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. 2001. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 108(4):516-20
13. Bohnhoff M, Miller CP, Martin WR. 1964. Resistance of the mouses intestinal tract to experimental salmonella infection. I. Factors which interfere with the initiation of infection by oral inoculation. J. Exp. Med. 120:805-16
14. Booijink CCGM, El-Aidy S, Rajilic-StojanovicM, Heilig HGHJ, Troost FJ, et al. 2010. High temporal and inter-individual variation detected in the human ileal microbiota. Environ.Microbiol. 12(12):3213-27
15. Bornside GH, Cohn I. 1965. The normal microbial flora: comparative bacterial flora of animals and man. Am. J. Dig. Dis. 10(10):844-52
16. Brinig MM, Lepp PW, Ouverney CC, Armitage GC, Relman DA. 2003. Prevalence of bacteria of division TM7 in human subgingival plaque and their association with disease. Appl. Environ. Microbiol. 69(3):1687-94
17. Brugman S, Klatter FA, Visser JTJ, Wildeboer-Veloo ACM, Harmsen HJM, et al. 2006. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat: Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49(9):2105-8
18. Burger-van Paassen N, Vincent A, Puiman PJ, van der Sluis M, Bouma J, et al. 2009. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem. J. 420(2):211-19
19. Chen T, Yu W-H, Izard J, Baranova OV, Lakshmanan A, Dewhirst FE. 2010. The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database: J. Biol. Databases Curation. 2010:baq013
20. Chen X, KatcharK,Goldsmith JD, NanthakumarN,Cheknis A, et al. 2008.Amousemodel of Clostridium difficile-associated disease. Gastroenterology 135(6):1984-92
21. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, et al. 2012. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149(7):1578-93
22. Corthier G, Muller MC, Elmer GW, Lucas F, Dubos-Ramare F. 1989. Interrelationships between digestive proteolytic activities and production and quantitation of toxins in pseudomembranous colitis induced by Clostridium difficile in gnotobiotic mice. Infect. Immun. 57(12):3922-27
23. Dabbagh K, Dahl ME, Stepick-Biek P, Lewis DB. 2002. Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells. J. Immunol. 168(9):4524-30
24. Danilowicz D, Posnock E, Chase R, Spencer FC. 1974. Salmonella septicemia after open heart surgery in an asymptomatic carrier. Am. J. Cardiol. 34(7):864-67
25. De La CochetiereMF, Durand T, Lepage P, Bourreille A, Galmiche JP, Dore J. 2005. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J. Clin.Microbiol. 43(11):5588-92
26. Dethlefsen L, Huse S, SoginML, Relman DA. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6:e280
27. Dethlefsen L, Relman DA. 2011. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. USA 108(Suppl. 1):4554-61
28. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, et al. 2010. The human oral microbiome. J. Bacteriol. 192(19):5002-17
29. Dharmani P, Srivastava V, Kissoon-Singh V, Chadee K. 2009. Role of intestinal mucins in innate host defense mechanisms against pathogens. J. Innate Immun. 1(2):123-35
30. Di Caprio JM, Rantz LA. 1950. Effects of terramycin on the bacterial flora of the bowel in man. AMA Arch. Intern. Med. 86(5):649-57
31. Donskey CJ, Hujer AM, Das SM, Pultz NJ, Bonomo RA, Rice LB. 2003. Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J. Microbiol. Methods 54(2):249-56
32. Douce G, Goulding D. 2010. Refinement of the hamster model of Clostridium difficile disease. Methods Mol. Biol. 646(Chapter 14):215-27
33. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. 2005. Diversity of the human intestinal microbial flora. Science 308(5728):1635-38
34. Elli M, Colombo O, Tagliabue A. 2010. A common core microbiota between obese individuals and their lean relatives? Evaluation of the predisposition to obesity on the basis of the fecal microflora profile. Med. Hypotheses 75(4):350-52
35. Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. 1988. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29(8):1035-41
36. FallaniM, Young D, Scott J, Norin E, Amarri S, et al. 2010. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J. Pediatr. Gastroenterol. Nutr. 51(1):77-84
37. Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, et al. 2012. Bifidobacterial surfaceexopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc. Natl. Acad. Sci. USA 109(6):2108-13
38. Ferreira RBR, Gill N, Willing BP, Antunes LCM, Russell SL, et al. 2011. The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization. PLoS ONE 6(5):e20338
39. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. 2007. Molecularphylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 104(34):13780-85
40. Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, et al. 2010. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8(3):292-300
41. Ghosh S, Dai C, Brown K, Rajendiran E, Makarenko S, et al. 2011. Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 301(1):G39-49
42. Giongo A, Gano KA,Crabb DB,Mukherjee N, Novelo LL, et al. 2011. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 5(1):82-91
43. Gronlund MM, Lehtonen OP, Eerola E, Kero P. 1999. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J. Pediatr. Gastroenterol. Nutr. 28(1):19-25
44. Gu S, Chen D, Zhang J-N, Lv X, Wang K, et al. 2013. Bacterial community mapping of the mouse gastrointestinal tract. PLoS ONE 8(10):e74957
45. Hall IC, OToole E. 1935. Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficilis. Arch. Pediatr. Adolesc. Med. 49:390-402
46. Hara N, Alkanani AK, Ir D, Robertson CE, Wagner BD, et al. 2012. Prevention of virus-induced type 1 diabetes with antibiotic therapy. J. Immunol. 189(8):3805-14
47. Hayes GW, Keating CL, Newman JS. 1993. The golden anniversary of the silver bullet. JAMA 270(13):1610-11
48. Herbst T, Sichelstiel A, Schär C, Yadava K, Burki K, et al. 2011. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am. J. Respir. Crit. CareMed. 184(2):198-205
49. Hill DA, Siracusa MC, Abt MC, Kim BS, Kobuley D, et al. 2012. Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat. Med. 18(4):538-46
50. Hugenholtz P, Tyson GW, Webb RI, Wagner AM, Blackall LL. 2001. Investigation of candidate division TM7, a recently recognized major lineage of the domain Bacteria with no known pure-culture representatives. Appl. Environ. Microbiol. 67(1):411-19
51. Human Microbiome Project Consortium. 2012. A framework for human microbiome research. Nature 486(7402):215-21
52. Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486(7402):207-14
53. Hunt JRF, Martinelli R, Adams VC, Rook GAW, Brunet LR. 2005. Intragastric administration of Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in amousemodel. Clin. Exp. Allergy 35(5):685-90
54. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485-98
55. Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, et al. 2009. Metabolomics reveals metabolic biomarkers of Crohns disease. PLoS ONE 4(7):e6386
56. Jernberg C, Lofmark S, Edlund C, Jansson JK. 2007. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 1(1):56-66
57. Johansson MEV, Larsson JMH, Hansson GC. 2011. The two mucus layers of colon are organized by theMUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl. Acad. Sci. USA 108(Suppl. 1):4659-65
58. Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. 2001. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107(1):129-34
59. Kamada N, Kim Y-G, Sham HP, Vallance BA, Puente JL, et al. 2012. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336(6086):1325-29
60. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. 2010. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38(Suppl. 1):D355-60
61. Kang S, Denman SE, Morrison M, Yu Z, Dore J, et al. 2010. Dysbiosis of fecal microbiota in Crohns disease patients as revealed by a custom phylogenetic microarray. Inflamm. Bowel Dis. 16(12):2034-42
62. Kelly CP, Pothoulakis C, LaMont JT. 1994. Clostridium difficile colitis. N. Engl. J. Med. 330(4):257-62
63. Kline KA, Fälker S, Dahlberg S, Normark S, Henriques-Normark B. 2009. Bacterial adhesins in hostmicrobe interactions. Cell Host Microbe 5(6):580-92
64. Kovatcheva-Datchary P, Zoetendal EG, Venema K, de Vos WM, Smidt H. 2009. Tools for the tract: understanding the functionality of the gastrointestinal tract. Ther. Adv. Gastroenterol. 2(4):9-22
65. Kwon J-W, Kim B-J, Song Y, Seo J-H, Kim T-H, et al. 2011. Changes in the prevalence of childhood asthma in Seoul from 1995 to 2008 and its risk factors. Allergy Asthma Immunol. Res. 3(1):27-33
66. Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF. 2011. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebocontrolled study. Aliment. Pharmacol. Ther. 33(8):922-29
67. Lepage P,HäslerR, Spehlmann ME,Rehman A, Zvirbliene A, et al. 2011. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141(1):227-36
68. Levy J. 2000. The effects of antibiotic use on gastrointestinal function. Am. J. Gastroenterol. 95(Suppl. 1):S8-10
69. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102(31):11070-75
70. Ley RE, Peterson DA, Gordon JI. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124(4):837-48
71. Lievin V, Peiffer I, Hudault S, Rochat F, Brassart D, et al. 2000. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47(5):646-52
72. LinsellWD, Fletcher AP. 1950. Laboratory and clinical experience with terramycin hydrochloride. Br. Med. J. 2(4690):1190-95
73. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, et al. 2007. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2(2):119-29
74. MaiX-M,Kull I,WickmanM, Bergstrom A. 2010. Antibiotic use in early life and development of allergic diseases: respiratory infection as the explanation. Clin. Exp. Allergy 40(8):1230-37
75. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, et al. 2006. Reduced diversity of faecal microbiota in Crohns disease revealed by a metagenomic approach. Gut 55(2):205-11
76. Martens EC, Roth R, Heuser JE, Gordon JI. 2009. Coordinate regulation of glycan degradation and polysaccharide capsule biosynthesis by a prominent human gut symbiont. J. Biol. Chem. 284(27):18445-57
77. Martinez-Martinez RE, Abud-Mendoza C, Patino-Marin N, Rizo-Rodriguez JC, Little JW, Loyola- Rodriguez JP. 2009. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J. Clin. Periodontol. 36(12):1004-10
78. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122(1):107-18
79. Mazmanian SK, Round JL, Kasper DL. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453:620-25
80. McCall CE, Sanders WE, Boring JR, Brachman PS, Wikingsson M. 1964. Delineation of chronic carriers of Salmonella derby within an institution for incurables. Antimicrob. Agents Chemother. 10:717-21
81. McFarland LV. 2008. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 5(1):40-48
82. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. 1989. Nosocomial acquisition of Clostridium difficile infection. N. Engl. J. Med. 320(4):204-10
83. Mentula S, Harmoinen J, Heikkila M, Westermarck E, Rautio M, et al. 2005. Comparison between cultured small-intestinal and fecal microbiotas in beagle dogs. Appl. Environ. Microbiol. 71(8):4169-75
84. MillionM, Angelakis E, Paul M, Armougom F, Leibovici L, RaoultD. 2012. Comparativemeta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb. Pathog. 53(2):100-8
85. Moore PR, Evenson A. 1946. Use of sulfasuxidine, streptothricin, and streptomycin in nutritional studies with the chick. J. Biol. Chem. 165(2):437-41
86. Most H, Miller JW, Grossman EJ. 1950. Treatment of amebiasis with bacitracin and other antibiotics. Am. J. Trop. Med. Hyg. 30(4):491-97
87. Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, et al. 2013. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502(7469):96-99
88. NIH HMP Working Group, Peterson J, Garges S, Giovanni M, McInnes P, et al. 2009. The NIH Human Microbiome Project. Genome Res. 19(12):2317-23
89. Nord CE. 1993. The effect of antimicrobial agents on the ecology of the human intestinal microflora. Vet. Microbiol. 35(3-4):193-97
90. OHara AM, Shanahan F. 2006. The gut flora as a forgotten organ. EMBO Rep. 7(7):688-93
91. Olszak T, An D, Zeissig S, Vera MP, Richter J, et al. 2012. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336(6080):489-93
92. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, et al. 2006. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118(2):511-21
93. Pirzada OM, McGaw J, Taylor CJ, Everard ML. 2003. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics. J. Cystic Fibrosis 2(2):69-71
94. Pothoulakis C, LaMont JT. 1993. Clostridium difficile colitis and diarrhea. Gastroenterol. Clin. N. Am. 22(3):623-37
95. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59-65
96. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118(2):229-41
97. Risnes KR, Belanger K, MurkW, Bracken MB. 2011. Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 US children. Am. J. Epidemiol. 173(3):310-18
98. Roesch LFW, Lorca GL, Casella G, Giongo A, Naranjo A, et al. 2009. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J. 3(5):536-48
99. Rosenthal SL. 1969. Exacerbation of Salmonella enteritis due to ampicillin. N. Engl. J.Med. 280(3):147-48
100. Russell SL, Gold MJ, Hartmann M, Willing BP, Thorson L, et al. 2012. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 13(5):440-47
101. Russell SL, Gold MJ, Willing BP, Thorson L, McNagny KM, Finlay BB. 2013. Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes 4(2):158-64
102. Ruutu M, Thomas G, Steck R, Degli-Esposti MA, Zinkernagel MS, et al. 2012. β-glucan triggers spondylarthritis and Crohns disease-like ileitis in SKG mice. Arthritis Rheum. 64(7):2211-22
103. Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, et al. 2003. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 290(13):1749-56
104. Salman S, Rogerson SJ, Kose K, Griffin S, Gomorai S, et al. 2010. Pharmacokinetic properties of azithromycin in pregnancy. Antimicrob. Agents Chemother. 54(1):360-66
105. Saroglou G, Bisno AL. 1978. Salmonella bacteremia and gastroenteritis after oral ampicillin therapy for gonorrhea. South. Med. J. 71(8):964-65
106. Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, et al. 2013. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2:e01202
107. Schneeman BO. 2002. Gastrointestinal physiology and functions. Br. J. Nutr. 88(Suppl. 2):S159-63
108. Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, et al. 2008. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect. Immun. 76(10):4726-36
109. Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. 1998. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 351(9103):633-36
110. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 105(43):16731-36
111. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, et al. 2009. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15(8):1183-89
112. Sommer F, Bäckhed F. 2013. The gut microbiota-masters of host development and physiology. Nat. Rev. Microbiol. 11(4):227-38
113. Sonnenburg JL, Angenent LT, Gordon JI. 2004. Getting a grip on things: How do communities of bacterial symbionts become established in our intestine? Nat. Immunol. 5(6):569-73
114. SouthernKW,Barker PM, Solis-MoyaA, Patel L. 2012. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst. Rev. 11:CD002203
115. Stecher B, Robbiani R,Walker AW,Westendorf AM, BarthelM, et al. 2007. Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 5(10):2177-89
116. Sydora BC, Tavernini MM, Doyle JSG, Fedorak RN. 2005. Association with selected bacteria does not cause enterocolitis in IL-10 gene-deficient mice despite a systemic immune response. Dig. Dis. Sci. 50(5):905-13
117. Tamboli CP, Neut C, Desreumaux P, Colombel JF. 2004. Dysbiosis in inflammatory bowel disease. Gut 53(1):1-4
118. Tedesco FJ, Barton RW, Alpers DH. 1974. Clindamycin-associated colitis: a prospective study. Ann. Intern. Med. 81(4):429-33
119. Thavagnanam S, Fleming J, Bromley A, Shields MD, Cardwell CR. 2008. A meta-analysis of the association between caesarean section and childhood asthma. Clin. Exp. Allergy 38(4):629-33
120. Thuny F, Richet H, Casalta J-P, Angelakis E, Habib G, Raoult D. 2010. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS ONE 5(2):e9074
121. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. 2013. Infant antibiotic exposures and early-life body mass. Int. J. Obes. 37(1):16-23
122. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3(4):213-23
123. Turnbaugh PJ, HamadyM, Yatsunenko T, Cantarel BL, Duncan A, et al. 2009. A core gut microbiome in obese and lean twins. Nature 457(7228):480-84
124. Turnbaugh PJ, Ley RE,Mahowald MA,Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027-31
125. Vaahtovuo J, Munukka E, Korkeamäki M, Luukkainen R, Toivanen P. 2008. Fecal microbiota in early rheumatoid arthritis. J. Rheumatol. 35(8):1500-5
126. van Nimwegen FA, Penders J, Stobberingh EE, Postma DS, Koppelman GH, et al. 2011. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J. Allergy Clin. Immunol. 128(5):948-55.e3
127. Vebø HC, Sekelja M, Nestestog R, Storrø O, Johnsen R, et al. 2011. Temporal development of the infant gut microbiota in immunoglobulin E-sensitized and nonsensitized children determined by the GA-map infant array. Clin. Vaccine Immunol. 18(8):1326-35
128. Warny M, Pepin J, Fang A, Killgore G, Thompson A, et al. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366(9491):1079-84
129. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, et al. 2010. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139(6):1844-54.e1
130. Willing BP, Vacharaksa A, Croxen M, Thanachayanont T, Finlay BB. 2011. Altering host resistance to infections through microbial transplantation. PLoS ONE 6(10):e26988
131. Wlodarska M, Willing B, Keeney KM, Menendez A, Bergstrom KS, et al. 2011. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 79(4):1536-45
132. Young VB, Schmidt TM. 2004. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J. Clin. Microbiol. 42(3):1203-6
133. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, et al. 2009. Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. USA 106(7):2365-70
134. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. 2008. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57(11):1605-15
135. Zuo H-J, Xie Z-M, ZhangW-W, Li Y-R, Wang W, et al. 2011. Gut bacteria alteration in obese people and its relationship with gene polymorphism. World J. Gastroenterol. 17(8):1076-81